JURA Bio
About:
Jura Bio is a therapeutics company focused on translating successes in CAR-T to autoimmune disorders.
Website: http://jurabio.com/
Top Investors: John Ballantyne, Fontus Capital, Michael Chambers, Josh Ellington
Description:
Jura Bio is a therapeutics company focused on translating successes in CAR-T to autoimmune disorders. Elizabeth Baker Wood and Julie Norville founded it, with its headquarters in Somerville in Massachusetts.
Total Funding Amount:
$16.1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Somerville, Massachusetts, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)jurabio.com
Founders:
Elizabeth Wood, Julie Norville
Number of Employees:
1-10
Last Funding Date:
2023-09-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai